YU15301A - The use of r (+)-alfa-(2,3-dimetoxyphfenil) -1-[2-(4-fluorophfenyl) ethyl] -4-piperidinemethanol for the ttreatment of sleep disorders
- Google Patents
The use of r (+)-alfa-(2,3-dimetoxyphfenil) -1-[2-(4-fluorophfenyl) ethyl] -4-piperidinemethanol for the ttreatment of sleep disorders
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmceuticals Inc.filedCriticalAventis Pharmceuticals Inc.
Publication of YU15301ApublicationCriticalpatent/YU15301A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The use of r (+) -α - (2,3- dimetoxyphfenil) -1-[2-(4- fluorophfenyl) ethyl]-4- piperidinementhanol for the treatment of sllep disordersthe process for treating a patient who suffers of sleep disorder is giving the patient effective dosage of R-(+)α-(2,3-dimetoxyphfenil)-1-[2-(4- fluorophenyl)ethyl]-4-piperidinementhanol or other pharmaceutically acceptable salts to the patient who is in need of such treatment.
YU15301A1988-09-281999-07-29The use of r (+)-alfa-(2,3-dimetoxyphfenil) -1-[2-(4-fluorophfenyl) ethyl] -4-piperidinemethanol for the ttreatment of sleep disorders
YU15301A
(en)
Use of inhibitors of ornitine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease and process to prepare (2s,5s)-5-fluoromethylornithine